{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:20:07Z","timestamp":1785799207901,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04321-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:57:52Z","timestamp":1775548672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics exploration of hypoxia in gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Yingjie","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"3","key":"4321_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4321_CR2","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3748\/wjg.v22.i8.2403","volume":"22","author":"A Digklia","year":"2016","unstructured":"Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403\u201314.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4321_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-025-01684-4","volume":"18","author":"T Shang","year":"2025","unstructured":"Shang T, et al. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol. 2025;18(1):32.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4321_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.","journal-title":"Mol Cancer"},{"key":"4321_CR5","doi-asserted-by":"crossref","unstructured":"Infantino V, et al. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Int J Mol Sci. 2021;22(11):5703.","DOI":"10.3390\/ijms22115703"},{"issue":"5","key":"4321_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4321_CR7","doi-asserted-by":"crossref","unstructured":"Jiao Y, et al. A hypoxia molecular signature-based prognostic model for endometrial cancer patients. Int J Mol Sci. 2023;24(2):1675.","DOI":"10.3390\/ijms24021675"},{"key":"4321_CR8","doi-asserted-by":"publisher","first-page":"680435","DOI":"10.3389\/fimmu.2021.680435","volume":"12","author":"R Abou Khouzam","year":"2021","unstructured":"Abou Khouzam R, et al. An eight-gene hypoxia signature predicts survival in pancreatic cancer and is associated with an immunosuppressed tumor microenvironment. Front Immunol. 2021;12:680435.","journal-title":"Front Immunol"},{"issue":"11","key":"4321_CR9","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1078-0432.CCR-23-1526","volume":"30","author":"YJ Han","year":"2024","unstructured":"Han YJ, et al. The VEGF-hypoxia signature is upregulated in basal-like breast tumors from women of African ancestry and associated with poor outcomes in breast cancer. Clin Cancer Res. 2024;30(11):2609\u201318.","journal-title":"Clin Cancer Res"},{"key":"4321_CR10","doi-asserted-by":"crossref","unstructured":"Lu Z, et al. Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance. Mol Cancer. 2026;25(1):58.","DOI":"10.1186\/s12943-026-02572-2"},{"issue":"1","key":"4321_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4321_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","volume":"102","author":"FM Buffa","year":"2010","unstructured":"Buffa FM, et al. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer. 2010;102(2):428\u201335.","journal-title":"Br J Cancer"},{"issue":"17","key":"4321_CR13","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","volume":"19","author":"A Eustace","year":"2013","unstructured":"Eustace A, et al. A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. Clin Cancer Res. 2013;19(17):4879\u201388.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4321_CR14","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-17-0038","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, et al. A gene signature for selecting benefit from hypoxia modification of radiotherapy for high-risk bladder cancer patients. Clin Cancer Res. 2017;23(16):4761\u20138.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"4321_CR15","doi-asserted-by":"publisher","first-page":"15215","DOI":"10.1074\/jbc.M511408200","volume":"281","author":"GP Elvidge","year":"2006","unstructured":"Elvidge GP, et al. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem. 2006;281(22):15215\u201326.","journal-title":"J Biol Chem"},{"key":"4321_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.04.019","volume":"31","author":"L Yang","year":"2018","unstructured":"Yang L, et al. Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer. EBioMedicine. 2018;31:182\u20139.","journal-title":"EBioMedicine"},{"issue":"7","key":"4321_CR17","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","volume":"67","author":"SC Winter","year":"2007","unstructured":"Winter SC, et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res. 2007;67(7):3441\u20139.","journal-title":"Cancer Res"},{"issue":"17","key":"4321_CR18","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","volume":"71","author":"K Toustrup","year":"2011","unstructured":"Toustrup K, et al. Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer. Cancer Res. 2011;71(17):5923\u201331.","journal-title":"Cancer Res"},{"issue":"7","key":"4321_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3109\/02841861003614343","volume":"49","author":"BS Sorensen","year":"2010","unstructured":"Sorensen BS, et al. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro. Acta Oncol. 2010;49(7):895\u2013905.","journal-title":"Acta Oncol"},{"key":"4321_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/1471-2407-13-518","volume":"13","author":"TL Khong","year":"2013","unstructured":"Khong TL, et al. Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer. BMC Cancer. 2013;13:518.","journal-title":"BMC Cancer"},{"issue":"12","key":"4321_CR21","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739\u201340.","journal-title":"Bioinformatics."},{"key":"4321_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics. 2010;11:367.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4321_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12964-019-0397-4","volume":"17","author":"W Hu","year":"2019","unstructured":"Hu W, et al. Subtyping of microsatellite instability-high colorectal cancer. Cell Commun Signal. 2019;17(1):79.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"4321_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907\u201315.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4321_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"1","key":"4321_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/bioinformatics\/btp612","volume":"26","author":"L Wang","year":"2010","unstructured":"Wang L, et al. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics. 2010;26(1):136\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"4321_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. XCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"7","key":"4321_CR28","doi-asserted-by":"publisher","first-page":"114424","DOI":"10.1016\/j.celrep.2024.114424","volume":"43","author":"H Chen","year":"2024","unstructured":"Chen H, et al. Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer. Cell Rep. 2024;43(7):114424.","journal-title":"Cell Rep"},{"issue":"1","key":"4321_CR29","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1038\/s41598-024-52647-7","volume":"14","author":"C Li","year":"2024","unstructured":"Li C, et al. Identification of a lipid homeostasis-related gene signature for predicting prognosis, immunity, and chemotherapeutic effect in patients with gastric cancer. Sci Rep. 2024;14(1):2895.","journal-title":"Sci Rep"},{"key":"4321_CR30","doi-asserted-by":"publisher","first-page":"1559489","DOI":"10.3389\/fonc.2025.1559489","volume":"15","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, et al. Integrative single-cell atlas unveils heterogeneity and prognostic value of cancer-associated fibroblasts in gastric cancer. Front Oncol. 2025;15:1559489.","journal-title":"Front Oncol"},{"issue":"7","key":"4321_CR31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"4321_CR32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4321_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"4321_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000."},{"key":"4321_CR35","doi-asserted-by":"crossref","unstructured":"Hu W, et al. Deciphering molecular properties of hypermutated gastrointestinal cancer. J Cell Mol Med. 2018;23(1):370\u20139.","DOI":"10.1111\/jcmm.13941"},{"issue":"1","key":"4321_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4321_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","volume":"74","author":"IB Barsoum","year":"2014","unstructured":"Barsoum IB, et al. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res. 2014;74(3):665\u201374.","journal-title":"Cancer Res"},{"issue":"2","key":"4321_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, et al. PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193\u2013204.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"4321_CR39","first-page":"1439","volume":"41","author":"M Hu","year":"2019","unstructured":"Hu M, et al. MicroRNAs and the PTEN\/PI3K\/Akt pathway in gastric cancer (Review). Oncol Rep. 2019;41(3):1439\u201354.","journal-title":"Oncol Rep"},{"issue":"5","key":"4321_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3892\/ol.2014.1963","volume":"7","author":"J Zhang","year":"2014","unstructured":"Zhang J, et al. Inhibition of phosphoinositide 3-kinase\/Akt pathway decreases hypoxia inducible factor-1alpha expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells. Oncol Lett. 2014;7(5):1401\u20138.","journal-title":"Oncol Lett"},{"issue":"12","key":"4321_CR41","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1007\/s12094-025-03956-4","volume":"27","author":"M Kuhne","year":"2025","unstructured":"Kuhne M, et al. TH-302 (evofosfamide) monotherapy exerts anticancer activity in Ewing\u2019s sarcoma cells under hypoxia. Clin Transl Oncol. 2025;27(12):4508\u201318.","journal-title":"Clin Transl Oncol"},{"issue":"50","key":"4321_CR42","doi-asserted-by":"publisher","first-page":"19579","DOI":"10.1073\/pnas.0809763105","volume":"105","author":"H Zhang","year":"2008","unstructured":"Zhang H, et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A. 2008;105(50):19579\u201386.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"4321_CR43","doi-asserted-by":"publisher","first-page":"eaba5996","DOI":"10.1126\/sciadv.aba5996","volume":"6","author":"Y Qiao","year":"2020","unstructured":"Qiao Y, et al. Engineered algae: a novel oxygen-generating system for effective treatment of hypoxic cancer. Sci Adv. 2020;6(21):eaba5996.","journal-title":"Sci Adv"},{"issue":"5","key":"4321_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2023.01.038","volume":"164","author":"L Decourtye-Espiard","year":"2023","unstructured":"Decourtye-Espiard L, Guilford P. Hereditary diffuse gastric cancer. Gastroenterology. 2023;164(5):719\u201335.","journal-title":"Gastroenterology"},{"issue":"10","key":"4321_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.4161\/cc.10.10.15638","volume":"10","author":"I Nathke","year":"2011","unstructured":"Nathke I, Rocha S. Antagonistic crosstalk between APC and HIF-1alpha. Cell Cycle. 2011;10(10):1545\u20137.","journal-title":"Cell Cycle"},{"issue":"2","key":"4321_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41577-025-01221-x","volume":"26","author":"Q Sun","year":"2026","unstructured":"Sun Q, Dong C. Regulators of CD8(+) T cell exhaustion. Nat Rev Immunol. 2026;26(2):129\u201351.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4321_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4321_CR48","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1158\/2326-6066.CIR-24-1144","volume":"13","author":"Y Naoi","year":"2025","unstructured":"Naoi Y, et al. Close spatial interactions between cancer cells and cancer-associated fibroblasts suppress antitumor immunity. Cancer Immunol Res. 2025;13(9):1471\u201384.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"4321_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13058-023-01684-7","volume":"25","author":"N Chuangchot","year":"2023","unstructured":"Chuangchot N, et al. Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3\/AKT pathways. Breast Cancer Res. 2023;25(1):86.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"4321_CR50","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41388-021-02172-y","volume":"41","author":"L Avalle","year":"2022","unstructured":"Avalle L, et al. STAT3 induces breast cancer growth via ANGPTL4, MMP13 and STC1 secretion by cancer associated fibroblasts. Oncogene. 2022;41(10):1456\u201367.","journal-title":"Oncogene"},{"key":"4321_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","volume":"518","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, et al. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Lett. 2021;518:35\u201348.","journal-title":"Cancer Lett"},{"issue":"16","key":"4321_CR52","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1158\/0008-5472.CAN-19-3803","volume":"80","author":"T Uchihara","year":"2020","unstructured":"Uchihara T, et al. Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing beta1 integrin, enhancing drug resistance. Cancer Res. 2020;80(16):3222\u201335.","journal-title":"Cancer Res"},{"issue":"17","key":"4321_CR53","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","volume":"77","author":"LJ Scott","year":"2017","unstructured":"Scott LJ. Tocilizumab: a review in rheumatoid arthritis. Drugs. 2017;77(17):1865\u201379.","journal-title":"Drugs"},{"issue":"4","key":"4321_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med. 2017;377(4):317\u201328.","journal-title":"N Engl J Med"},{"issue":"12","key":"4321_CR55","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41556-022-01054-z","volume":"24","author":"Z Wang","year":"2022","unstructured":"Wang Z. Caf heterogeneity and dynamics. Nat Cell Biol. 2022;24(12):1686.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"4321_CR56","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.xcrm.2025.102395","volume":"6","author":"V Boeker","year":"2025","unstructured":"Boeker V, Kalluri R. Insights into the relevance of targeting fibroblasts to control cancer. Cell Rep Med. 2025;6(11):102395.","journal-title":"Cell Rep Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04321-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:17:37Z","timestamp":1778735857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4321"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04321-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potentially identifiable human images or data is presented in this study. No animal or human studies are presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}